Rezultati - Bijina Balakrishnan

  • Showing 1 - 5 results of 5
Refine Results
  1. 1
    Novel mRNA-Based Therapy Reduces Toxic Galactose Metabolites and Overcomes Galactose Sensitivity in a Mouse Model of Classic Galactosemia

    Novel mRNA-Based Therapy Reduces Toxic Galactose Metabolites and Overcomes Galactose Sensitivity in a Mouse Model of Classic Galactosemia od Bijina Balakrishnan, An Ding, Vi Nguyen, Christine DeAntonis, Paolo G.V. Martini, Kent Lai

    Izdano 2019
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  2. 2
    Functional and molecular studies in primary carnitine deficiency

    Functional and molecular studies in primary carnitine deficiency od Marta Frigeni, Bijina Balakrishnan, Xue Yin, Fernanda R.O. Calderon, Rong Mao, Marzia Pasquali, Nicola Longo

    Izdano 2017
    Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  3. 3
    Improvement of Mutant Galactose-1-Phosphate Uridylyltransferase (GALT) Activity by FDA-Approved Pharmacochaperones: A Preliminary Study

    Improvement of Mutant Galactose-1-Phosphate Uridylyltransferase (GALT) Activity by FDA-Approved Pharmacochaperones: A Preliminary Study od Bernardina Scafuri, Stefania Piscosquito, Giulia Giliberti, Angelo Facchiano, Jaden Miner, Bijina Balakrishnan, Kent Lai, Anna Marabotti

    Izdano 2025
    Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  4. 4
    Assessment of Long‐Term Safety and Efficacy of Purple Sweet Potato Color (<scp>PSPC</scp>) and <i>Myo‐</i>Inositol (<scp>MI</scp>) Treatment for Motor Related and Behavioral Phenotypes in a Mouse Model of Classic Galactosemia

    Assessment of Long‐Term Safety and Efficacy of Purple Sweet Potato Color (<scp>PSPC</scp>) and <i>Myo‐</i>Inositol (<scp>MI</scp>) Treatment for Motor Related and Behavioral Phenot... od Olivia Bellagamba, Aaron j Guo, Sandhya Senthilkumar, Synneva Hagen Lillevik, Davide De Biase, Kent Lai, Bijina Balakrishnan

    Izdano 2025
    Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  5. 5
    AAV-based gene therapy prevents and halts the progression of dilated cardiomyopathy in a mouse model of phosphoglucomutase 1 deficiency (PGM1-CDG)

    AAV-based gene therapy prevents and halts the progression of dilated cardiomyopathy in a mouse model of phosphoglucomutase 1 deficiency (PGM1-CDG) od Bijina Balakrishnan, Ruqaiah Altassan, Rohit Budhraja, Willisa Liou, Arielle Lupo, Sarah L. Bryant, Anastasiya Mankouski, Silvia Radenkovic, Graeme Preston, Akhilesh Pandey, Sihem Boudina, Tamás Kozicz, Éva Morava, Kent Lai

    Izdano 2023
    Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:

Iskalna orodja: